Soligenix, Inc. Gains 134.4%
Thu, Jul 31, 2025 at 07:36 PM
Soligenix, Inc. (SNGX:NASDAQ) jumped higher at $2.93, a gain of 134.4%. On Thu, Jul 31, 2025, SNGX:NASDAQ touched a New 2-Week High of $2.93. The stock got featured on our News Catalysts scanner on Thu, Jul 31, 2025 at 02:54 PM in the 'BIOTECH' category. From Thu, Jul 17, 2025, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Jul 31, 2025 at $5.38 with a volume of 373M+.
About Soligenix, Inc. (SNGX:NASDAQ)
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Hempacco Co., Inc. (HPCO:NASDAQ), 800%
- Soligenix, Inc. (SNGX:NASDAQ), 134.4%
- Pop Culture Group Co., Ltd (CPOP:NASDAQ), 129.51%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 73.06%
- Recon Technology, Ltd. (RCON:NASDAQ), 65.44%
- Earlyworks Co., Ltd (ELWS:NASDAQ), 51.76%
- Lixiang Education Holding Co., Ltd. (LXEH:NASDAQ), 51.43%
- Newegg Commerce, Inc. (NEGG:NASDAQ), 41.85%
- Nvni Group Limited (NVNI:NASDAQ), 34.51%